A Growing Body
of Evidence
Browse the expanding collection of published research featuring our seed amplification assay (SAA) technology.
Scientific Paper
npj Parkinson's Disease
Skin α-synuclein seed amplification assay for the identification of multiple system atrophy
September 8, 2026
Read MoreScientific Paper
Journal of Parkinson's Disease
Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies
September 16, 2026
Read MoreScientific Paper
Neurology
Alpha-Synuclein Seed Amplification Assay in CSF, Skin, and Submandibular Gland From Incidental Lewy Body Disease and Parkinson Disease
July 28, 2026
Read MoreScientific Paper
Journal of Neuropathology & Experimental Neurology
Multisite study: Predicting Lewy body disease using skin biopsy α-synuclein seed amplification assays
September 1, 2026
Read MoreScientific Paper
npj Parkinson's Disease
Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson’s disease
April 14, 2026
Read MoreScientific Paper
Movement Disorders
Rethinking Mitochondrial Parkinson's Disease in the α-Synuclein Seed Amplification Assays Era
May 3, 2026
Read MoreScientific Paper
Journal of Parkinson's Disease
Collaborative action for biomarker breakthroughs: Validating α-synuclein seed amplification assays in Parkinson's disease
March 19, 2026
Read MoreScientific Paper
Alzheimer's & Dementia
Prevalence of Lewy body pathology and phenotypic associations in patients with mild cognitive impairment: Evidence from the Interceptor study
June 15, 2026
Read MoreScientific Paper
Alzheimer's & Dementia
Atrophy signature for alpha-synuclein copathology in Alzheimer's disease
May 24, 2026
Read MoreScientific Paper
Neurobioogy of Disease
Combination of CSF α-synuclein seed amplification assay and amyloid-β42 predicts cognitive decline in Parkinson's disease
May 16, 2026
Read MoreScientific Paper
Alzheimer's & Dementia
Effects of α-synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging
May 3, 2026
Read MoreScientific Paper
Alzheimer's & Dementia
Alpha-synuclein co-pathology in a real-world early Alzheimer's disease cohort
March 24, 2026
Read MoreScientific Paper
Journal of Parkinson's Disease
Faster reaction times of CSF alpha-synuclein seed amplification assay predict the diffuse malignant subtype of Parkinson's disease at 10-year follow-up
January 29, 2026
Read MoreScientific Paper
Journal of Parkinson's Disease
Analysis of α-synuclein seed amplification assay in carriers of GBA1 and LRRK2 pathogenic variants
January 23, 2026
Read MoreScientific Paper
Neurobiology of Disease
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease
January 1, 2026
Read More
Get in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-ɑSYN test. Order your shipping kits today and help move your patient beyond a probable diagnosis.
